Renowned economist Nouriel Roubini recently expressed his apprehensions about President-elect Trump's second term.

Get global perspectives and insights from CEOs on the biggest stories in business. New jobs and developments are booming, but ...

For the first time in 30 years, a drug used to treat endometriosis will be listed on the pharmaceutical benefits scheme.